MADRID (Reuters) - Spanish pharmaceuticals group Grifols said on Monday it would finance its $1.675 billion acquisition of Novartis's blood transfusion diagnostics unit with a $1.5 billion loan from banks.

Grifols, the world's third-largest blood products maker, said Nomura, BBVA and Morgan Stanley would provide the financing.

(Reporting by Sarah White, editing by Patrick Graham)